Decreasing Enterobacter sakazakii (Cronobacter spp.) food contamination level with bacteriophages: Prospects and problems

Microbial Biotechnology

Volumn 1, Issue 6, 2008, Pages 532-543

  Zuber, Sophie ^a   Boissin Delaporte, Catherine ^a   Michot, Lise ^a   Iversen, Carol ^a,b   Diep, Benjamin ^a   Brüssow, Harald ^a   Breeuwer, Pieter ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

TREHALOSE;

ARTICLE; ARTIFICIAL MILK; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATION; COLONY FORMING UNIT; DNA HYBRIDIZATION; ENTEROBACTER SAKAZAKII; ESCHERICHIA COLI; FOOD CONTAMINATION; FREEZE DRYING; HIGH TEMPERATURE; HOST RANGE; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RIBOTYPING; SAMPLING; SOUTHERN BLOTTING;

ENTEROBACTER SAKAZAKII; FOOD CONTAMINATION; FOOD MICROBIOLOGY; HOST SPECIFICITY; MYOVIRIDAE; SEWAGE;

BACTERIA (MICROORGANISMS); ENTEROBACTER SAKAZAKII; ESCHERICHIA COLI; MYOVIRIDAE;

EID: 70349399064     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/j.1751-7915.2008.00058.x     Document Type: Article

References (48)

1. van Acker, J., de Smet, F., Muyldermans, G., Bougatef, A., Naessens, A., and Lauwers, S. (2001) Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol 39: 293-297.
2. Ashelford, K.E., Day, M.J., and Fry, J.C. (2003) Elevated abundance of bacteriophage infecting bacteria in soil. Appl Environ Microbiol 69: 285-289.
3. Atterbury, R.J., Connerton, P.L., Dodd, C.E., Rees, C.E., and Connerton, I.F. (2003) Application of host-specific bacteriophages to the surface of chicken skin leads to a reduction in recovery of Campylobacter jejuni. Appl Environ Microbiol 69: 6302-6306.
4. Bruce, J. (1996) Automated system rapidly identifies and characterizes microorganisms in food. Food Technol 50: 77-81.
5. Bruttin, A., and Brüssow, H. (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 49: 2874-2878.
6. Brüssow, H. (2005) Phage therapy: the Escherichia coli experience. Microbiology 151: 2133-2140.
7. Brüssow, H., Canchaya, C., and Hardt, W.D. (2004) Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68: 560-602.
8. Canchaya, C., Proux, C., Fournous, G., Bruttin, A., and Brüssow, H. (2003) Prophage genomics. Microbiol Mol Biol Rev 67: 238-276.
9. Carlton, R.M., Noordman, W.H., Biswas, B., de Meester, E.D., and Loessner, M.J. (2005) Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol 43: 301-312.
10. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., and Brüssow, H. (2004) In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother 48: 2558-2569.
11. Comeau, A.M., Tétart, F., Trojet, S.N., Prère, M.F., and Krisch, H.M. (2007) Phage-Antibiotic Synergy (PAS): betalactam and quinolone antibiotic stimulate virulent phage growth. PLoS ONE 2: e799.
12. Fischetti, V.A. (2001) Phage antibacterials make a comeback. Nat Biotechnol 19: 734-735.
13. Forsythe, S.J. (2005) Enterobacter sakazakii and other bacteria in powdeerd infant milk formula. Matern Child Nutr 1: 44-50.
14. Goode, D., Allen, V.M., and Barrow, P.A. (2003) Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl Environ Microbiol 69: 5032-5036.
15. Greer, G.G. (2005) Bacteriophage control of foodborne bacteriat. J Food Prot 68: 1102-1111.
16. Guillaume-Gentil, O., Scheldeman, P., Marugg, J., Herman, L., Joosten, H., and Heyndrickx, M. (2002) Genetic heterogeneity in Bacillus sporothermodurans as demonstrated by ribotyping and repetitive extragenic palindromic-PCR fingerprinting. Appl Environ Microbiol 68: 4216-4224.
17. Hamilton, J.V., Lehane, M.J., and Braig, H.R. (2003) Isolation of Enterobacter sakazakii from midgut of Stomoxys calcitrans. Emerg Infect Dis 9: 1355-1356.
18. Iversen, C., Lehner, A., Mullane, N., Bidlas, E., Cleenwerck, I., Marugg, J., et al. (2007a) The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. BMC Evol Biol 7: 64.
19. Iversen, C., Lehner, A., Mullane, N., Marugg, J., Fanning, S., Stephan, R., and Joosten, H. (2007b) Identification of 'Cronobacter' spp. (Enterobacter sakazakii). J Clin Microbiol 45: 3814-3816.
20. Iversen, C., Mullane, N., McCardell, B., Tall, B.D., Lehner, A., Fanning, S., et al. (2008) Cronobacter gen. nov., a new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov. comb. nov., C. malonaticus sp. nov., C. turicensis sp. nov., C. muytjensii sp. nov., C. dublinensis sp. nov., Cronobacter genomospecies 1, and of three subspecies, C. dublinensis sp. nov. subsp. dublinensis subsp. nov., C. dublinensis sp. nov. subsp. lausannensis subsp. nov., and C. dublinensis sp. nov. subsp. lactaridi subsp. nov. Int J Syst Evol Microbiol 58: 1442-1447.
21. Jepson, C.D., and March, J.B. (2004) Bacteriophage lambda is a highly stable DNAvaccine delivery vehicle. Vaccine 22: 2413-2419.
22. Kasman, L.M., Kasman, A., Westwater, C., Dolan, J., Schmidt, M.G., and Norris, J.S. (2002) Overcoming the phage replication threshold:a mathematical model with implications for phage therapy. J Virol 76: 5557-5564.
23. Kennedy, J.E., Jr, Wei, C.I., and Oblinger, and J.L. (1986) Methodology for enumeration of coliphages in foods. Appl Environ Microbiol 51: 956-962.
24. Kim, K.P., Klumpp, J., and Loessner, M.J. (2007) Enterobacter sakazakii bacteriophages can prevent bacterial growth in reconstituted infant formula. Int J Food Microbiol 115: 195-203.
25. Kysela, D.T., and Turner, P.E. (2007) Optimal bacteriophage mutation rates for phage therapy. J Theor Biol 249: 411-421.
26. Leverentz, B., Conway, W.S., Alavidze, Z., Janisiewicz, W.J., Fuchs, Y., Camp, M.J., et al. (2001) Examination of bacteriophage as a biocontrol method for Salmonella on freshcut fruit: a model study. J Food Prot 64: 1116-1121.
27. Leverentz, B., Conway, W.S., Camp, M.J., Janisiewicz, W.J., Abuladze, T., Yang, M., et al. (2003) Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl Environ Microbiol 69: 4519-4526.
28. Leverentz, B., Conway, W.S., Janisiewicz, W., and Camp, M.J. (2004) Optimizing concentration and timing of a phage spray application to reduce Listeria monocytogenes on honeydew melon tissue. J Food Prot 67: 1682-1686.
29. Levin, B.R., and Bull, J.J. (2004) Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol 2: 166-173.
30. Loessner, M.J., Neugirg, E., Zink, R., and Scherer, S. (1993) Isolation, classification and molecular characterization of bacteriophages for Enterobacter species. J Gen Microbiol 139: 2627-2633.
31. Merril, C.R., Scholl, D., and Adhya, S.L. (2003) The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov 2: 489-497.
32. Monod, C., Repoila, F., Kutateladze, M., Tétart, F., and Krisch, H.M. (1997) The genome of the pseudo T-even bacteriophages, a diverse group that resembles T4. J Mol Biol 267: 237-249.
33. Mullane, N.R., Iversen, C., Healy, B., Walsh, C., Whyte, P., Wall, P.G., et al. (2007) Enterobacter sakazakii an emerging bacterial pathogen with implications for infant health. Minerva Pediatrica 59: 137-148.
34. Muytjens, H.L., Zanen, H.C., Sonderkamp, H.J., Kollee, L.A., Wachsmuth, I.K., and Farmer, J.J., III (1983) Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol 18: 115-120.
35. Muytjens, H.L., Roelofs-Willemse, H., and Jaspar, G.H. (1988) Quality of powdered substitutes for breast milk with regard to members of the family Enterobacteriaceae. J Clin Microbiol 26: 743-746.
36. O'Flynn, G., Ross, R.P., Fitzgerald, G.F., and Coffey, A. (2004) Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl Environ Microbiol 70: 3417-3424.
37. Ochman, H., and Selander, R.K. (1984) Standard reference strains of Escherichia coli from natural populations. J Bacteriol 157: 690-693.
38. Pagotto, F.J., Nazarowec-White, M., Bidawid, S., and Farber, J.M. (2003) Enterobacter sakazakii: infectivity and enterotoxin production in vitro and in vivo. J Food Prot 66: 370-375.
39. Payne, R.J., and Jansen, V.A. (2001) Understanding bacteriophage therapy as a density-dependent kinetic process. J Theor Biol 208: 37-48.
40. Payne, R.J., and Jansen, V.A. (2003) Pharmacokinetic principles of bacteriophage therapy. Clin Pharmacokinet 42: 315-325.
41. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual. Second edition. Cold Spring Harbor Laboratory Press.
42. Simmons, B.P., Gelfand, M.S., Haas, M., Metts, L., and Ferguson, J. (1989) Enterobacter sakazakii infections in neonates associated with intrinsic contamination of a powdered infant formula. Infect Control Hosp Epidemiol 10: 398-401.
43. Townsend, S.M., Hurrell, E., Gonzalez-Gomez, I., Lowe, J., Frye, J.G., Forsythe, S., and Badger, J.L. (2007) Enterobacter sakazakii invades brain capillary endothelial cells, persists in human macrophages influencing cytokine secretion and induces severe brain pathology in the neonatal rat. Microbiology 153: 3538-3547.
44. Tétart, F., Desplats, C., Kutateladze, M., Monod, C., Ackermann, H.W., and Krisch, H.M. (2001) Phylogeny of the major head and tail genes of the wide-ranging T4-type bacteriophages. J Bacteriol 183: 358-366.
45. Weld, R.J., Butts, C., and Heinemann, J.A. (2004) Models of phage growth and their applicability to phage therapy. J Theor Biol 227: 1-11.
46. Wiggins, B.A., and Alexander, M. (1985) Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems. Appl Environ Microbiol 49: 19-23.
47. World Health Organization (2004) Enterobacter sakazakii and other microorgansims in powdered infant formula. Geneva, Switzerland: World Health Organization.
48. Zuber, S., Ngom-Bru, C., Barretto, C., Bruttin, A., Brussow, H., and Denou, E. (2007) Genome analysis of phage JS98 defines a fourth major subgroup of T4-like phages in Escherichia coli. J Bacteriol 189: 8206-8214.